Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-23-000058
Filing Date
2023-05-05
Accepted
2023-05-05 17:13:54
Documents
1
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168332122145775.html 4  
1 FORM 4 wf-form4_168332122145775.xml 4 6134
  Complete submission text file 0001479290-23-000058.txt   7537
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LEVI STRAUSS & CO. 1155 BATTERY STREET SAN FRANCISCO CA 94111
Business Address
Beraud Jill (Reporting) CIK: 0001520061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 23894953